nodes	percent_of_prediction	percent_of_DWPC	metapath
Valrubicin—Idarubicin—breast cancer	0.206	0.531	CrCtD
Valrubicin—TOP2A—breast cancer	0.146	1	CbGaD
Valrubicin—Epirubicin—breast cancer	0.0945	0.244	CrCtD
Valrubicin—Doxorubicin—breast cancer	0.0875	0.225	CrCtD
Valrubicin—TOP2A—Idarubicin—breast cancer	0.0821	0.509	CbGbCtD
Valrubicin—Doxorubicin—Idarubicin—breast cancer	0.0441	0.177	CrCrCtD
Valrubicin—Epirubicin—Idarubicin—breast cancer	0.0441	0.177	CrCrCtD
Valrubicin—Daunorubicin—Idarubicin—breast cancer	0.0441	0.177	CrCrCtD
Valrubicin—TOP2A—Mitoxantrone—breast cancer	0.0353	0.219	CbGbCtD
Valrubicin—TOP2A—Epirubicin—breast cancer	0.0286	0.177	CbGbCtD
Valrubicin—Daunorubicin—Epirubicin—breast cancer	0.0203	0.0812	CrCrCtD
Valrubicin—Doxorubicin—Epirubicin—breast cancer	0.0203	0.0812	CrCrCtD
Valrubicin—Idarubicin—Epirubicin—breast cancer	0.0203	0.0812	CrCrCtD
Valrubicin—Daunorubicin—Doxorubicin—breast cancer	0.0187	0.0752	CrCrCtD
Valrubicin—Epirubicin—Doxorubicin—breast cancer	0.0187	0.0752	CrCrCtD
Valrubicin—Idarubicin—Doxorubicin—breast cancer	0.0187	0.0752	CrCrCtD
Valrubicin—TOP2A—Doxorubicin—breast cancer	0.0152	0.0942	CbGbCtD
Valrubicin—TOP2A—Gastric Cancer Network 2—MTDH—breast cancer	0.00104	0.0803	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—RRAD—breast cancer	0.000564	0.0436	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—KRT5—breast cancer	0.000391	0.0302	CbGpPWpGaD
Valrubicin—TOP2A—Gastric Cancer Network 1—CENPF—breast cancer	0.000381	0.0295	CbGpPWpGaD
Valrubicin—TOP2A—Gastric Cancer Network 1—UBE2C—breast cancer	0.000366	0.0283	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—KRT14—breast cancer	0.000364	0.0281	CbGpPWpGaD
Valrubicin—TOP2A—Gastric Cancer Network 2—UBE2C—breast cancer	0.000347	0.0268	CbGpPWpGaD
Valrubicin—Doxorubicin—NDUFS3—breast cancer	0.000306	0.147	CrCbGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MRE11A—breast cancer	0.000252	0.0195	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—GPX2—breast cancer	0.000246	0.019	CbGpPWpGaD
Valrubicin—TOP2A—Gastric Cancer Network 1—AURKA—breast cancer	0.000239	0.0185	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—BARD1—breast cancer	0.000222	0.0172	CbGpPWpGaD
Valrubicin—Epirubicin—AURKA—breast cancer	0.000221	0.106	CrCbGaD
Valrubicin—TOP2A—nipple—breast cancer	0.000215	0.227	CbGeAlD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—RB1CC1—breast cancer	0.000206	0.0159	CbGpPWpGaD
Valrubicin—TOP2A—G0 and Early G1—CCNE1—breast cancer	0.000198	0.0153	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—IGFBP3—breast cancer	0.000186	0.0144	CbGpPWpGaD
Valrubicin—TOP2A—G0 and Early G1—E2F1—breast cancer	0.000186	0.0143	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—STMN1—breast cancer	0.000178	0.0137	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—PER3—breast cancer	0.000177	0.0136	CbGpPWpGaD
Valrubicin—TOP2A—G0 and Early G1—CDK2—breast cancer	0.00016	0.0124	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—FASN—breast cancer	0.000159	0.0123	CbGpPWpGaD
Valrubicin—TOP2A—Docetaxel—Paclitaxel—breast cancer	0.000155	0.121	CbGdCrCtD
Valrubicin—Idarubicin—ABCC1—breast cancer	0.000152	0.0728	CrCbGaD
Valrubicin—TOP2A—Gefitinib—Lapatinib—breast cancer	0.000152	0.118	CbGdCrCtD
Valrubicin—TOP2A—Circadian rythm related genes—NR2F6—breast cancer	0.00015	0.0116	CbGpPWpGaD
Valrubicin—Epirubicin—PLA2G4A—breast cancer	0.000143	0.0683	CrCbGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TFF1—breast cancer	0.000133	0.0103	CbGpPWpGaD
Valrubicin—TOP2A—endometrium—breast cancer	0.00013	0.137	CbGeAlD
Valrubicin—TOP2A—Gastric Cancer Network 1—NOTCH1—breast cancer	0.000129	0.00999	CbGpPWpGaD
Valrubicin—Doxorubicin—AURKA—breast cancer	0.000127	0.0608	CrCbGaD
Valrubicin—TOP2A—Gastric Cancer Network 1—APC—breast cancer	0.000126	0.00977	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—breast cancer	0.000123	0.00951	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—CLDN4—breast cancer	0.000122	0.00945	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—ATF4—breast cancer	0.000122	0.00945	CbGpPWpGaD
Valrubicin—TOP2A—uterus—breast cancer	0.00012	0.126	CbGeAlD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—VDR—breast cancer	0.000119	0.00919	CbGpPWpGaD
Valrubicin—Idarubicin—TOP2A—breast cancer	0.000117	0.0561	CrCbGaD
Valrubicin—TOP2A—adipose tissue—breast cancer	0.000117	0.123	CbGeAlD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HES1—breast cancer	0.000116	0.00899	CbGpPWpGaD
Valrubicin—Epirubicin—ABCC1—breast cancer	0.000115	0.0552	CrCbGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NRG1—breast cancer	0.000114	0.00878	CbGpPWpGaD
Valrubicin—TOP2A—Topotecan—Irinotecan—breast cancer	0.00011	0.0857	CbGdCrCtD
Valrubicin—TOP2A—adrenal gland—breast cancer	0.000105	0.111	CbGeAlD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—DNMT1—breast cancer	0.000102	0.00788	CbGpPWpGaD
Valrubicin—TOP2A—bone marrow—breast cancer	0.000101	0.107	CbGeAlD
Valrubicin—TOP2A—Vindesine—Vinorelbine—breast cancer	9.85e-05	0.0766	CbGdCrCtD
Valrubicin—TOP2A—female gonad—breast cancer	9.78e-05	0.103	CbGeAlD
Valrubicin—TOP2A—Circadian rythm related genes—NRIP1—breast cancer	9.67e-05	0.00747	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—NME1—breast cancer	9.66e-05	0.00746	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—STMN1—breast cancer	9.47e-05	0.00732	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—ATM—breast cancer	9.17e-05	0.00708	CbGpPWpGaD
Valrubicin—Epirubicin—TOP2A—breast cancer	8.88e-05	0.0425	CrCbGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—breast cancer	8.79e-05	0.00679	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MRE11A—breast cancer	8.21e-05	0.00634	CbGpPWpGaD
Valrubicin—Daunorubicin—ABCC1—breast cancer	8.15e-05	0.039	CrCbGaD
Valrubicin—TOP2A—Gastric Cancer Network 2—CTNNB1—breast cancer	8.15e-05	0.00629	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FST—breast cancer	8e-05	0.00618	CbGpPWpGaD
Valrubicin—TOP2A—Vindesine—Vinblastine—breast cancer	7.87e-05	0.0613	CbGdCrCtD
Valrubicin—TOP2A—Paclitaxel—Docetaxel—breast cancer	7.73e-05	0.0601	CbGdCrCtD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—ABL1—breast cancer	7.52e-05	0.00581	CbGpPWpGaD
Valrubicin—Doxorubicin—NQO1—breast cancer	7.3e-05	0.0349	CrCbGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—CCNE1—breast cancer	7.29e-05	0.00563	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—breast cancer	7.16e-05	0.00553	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—RARB—breast cancer	6.98e-05	0.00539	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—E2F1—breast cancer	6.84e-05	0.00529	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—breast cancer	6.8e-05	0.00526	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—breast cancer	6.77e-05	0.00523	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—AHR—breast cancer	6.7e-05	0.00518	CbGpPWpGaD
Valrubicin—Doxorubicin—ABCC1—breast cancer	6.61e-05	0.0317	CrCbGaD
Valrubicin—TOP2A—Gastric Cancer Network 2—MYC—breast cancer	6.6e-05	0.0051	CbGpPWpGaD
Valrubicin—TOP2A—Gastric Cancer Network 2—EGFR—breast cancer	6.45e-05	0.00499	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—RAD51—breast cancer	6.35e-05	0.00491	CbGpPWpGaD
Valrubicin—TOP2A—lymph node—breast cancer	6.29e-05	0.0663	CbGeAlD
Valrubicin—Daunorubicin—TOP2A—breast cancer	6.29e-05	0.0301	CrCbGaD
Valrubicin—Daunorubicin—CYP1B1—breast cancer	6.23e-05	0.0298	CrCbGaD
Valrubicin—Doxorubicin—NOS3—breast cancer	6.16e-05	0.0295	CrCbGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—HPGDS—breast cancer	6.1e-05	0.00471	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IGFBP3—breast cancer	6.07e-05	0.00469	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—CPT1A—breast cancer	5.97e-05	0.00462	CbGpPWpGaD
Valrubicin—Doxorubicin—NOS2—breast cancer	5.95e-05	0.0285	CrCbGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ACHE—breast cancer	5.92e-05	0.00457	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDK2—breast cancer	5.9e-05	0.00456	CbGpPWpGaD
Valrubicin—TOP2A—Doxorubicin—Idarubicin—breast cancer	5.64e-05	0.0439	CbGdCrCtD
Valrubicin—TOP2A—Daunorubicin—Idarubicin—breast cancer	5.64e-05	0.0439	CbGdCrCtD
Valrubicin—TOP2A—Epirubicin—Idarubicin—breast cancer	5.64e-05	0.0439	CbGdCrCtD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—breast cancer	5.58e-05	0.00431	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—THBS1—breast cancer	5.52e-05	0.00426	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP7—breast cancer	5.52e-05	0.00426	CbGpPWpGaD
Valrubicin—TOP2A—Gastric Cancer Network 2—TP53—breast cancer	5.42e-05	0.00419	CbGpPWpGaD
Valrubicin—TOP2A—Vincristine—Vinorelbine—breast cancer	5.31e-05	0.0413	CbGdCrCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—breast cancer	5.27e-05	0.00407	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CCNE1—breast cancer	5.13e-05	0.00396	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—NCOA2—breast cancer	5.13e-05	0.00396	CbGpPWpGaD
Valrubicin—Doxorubicin—TOP2A—breast cancer	5.1e-05	0.0244	CrCbGaD
Valrubicin—TOP2A—Circadian rythm related genes—EZH2—breast cancer	5.06e-05	0.00391	CbGpPWpGaD
Valrubicin—Doxorubicin—CYP1B1—breast cancer	5.06e-05	0.0242	CrCbGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—TYMS—breast cancer	5.04e-05	0.00389	CbGpPWpGaD
Valrubicin—TOP2A—Vinorelbine—Vinblastine—breast cancer	4.97e-05	0.0387	CbGdCrCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PAK1—breast cancer	4.88e-05	0.00377	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—breast cancer	4.88e-05	0.00377	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—breast cancer	4.85e-05	0.00375	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—E2F1—breast cancer	4.82e-05	0.00372	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—breast cancer	4.73e-05	0.00366	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—RAD51C—breast cancer	4.69e-05	0.00362	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—SYNE1—breast cancer	4.69e-05	0.00362	CbGpPWpGaD
Valrubicin—Idarubicin—CYP2D6—breast cancer	4.67e-05	0.0224	CrCbGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGR1—breast cancer	4.57e-05	0.00353	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—STK11—breast cancer	4.43e-05	0.00343	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA1—breast cancer	4.43e-05	0.00343	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—EGR1—breast cancer	4.39e-05	0.00339	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AR—breast cancer	4.31e-05	0.00333	CbGpPWpGaD
Valrubicin—Daunorubicin—ABCG2—breast cancer	4.29e-05	0.0206	CrCbGaD
Valrubicin—TOP2A—Vinblastine—Vinorelbine—breast cancer	4.27e-05	0.0333	CbGdCrCtD
Valrubicin—TOP2A—Vincristine—Vinblastine—breast cancer	4.25e-05	0.0331	CbGdCrCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFA—breast cancer	4.16e-05	0.00322	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CDK2—breast cancer	4.15e-05	0.00321	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—breast cancer	4.14e-05	0.0032	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—breast cancer	4.12e-05	0.00318	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CENPF—breast cancer	4.09e-05	0.00316	CbGpPWpGaD
Valrubicin—Chest pain—Fluorouracil—breast cancer	4.03e-05	0.00106	CcSEcCtD
Valrubicin—Myalgia—Fluorouracil—breast cancer	4.03e-05	0.00106	CcSEcCtD
Valrubicin—Diarrhoea—Vinblastine—breast cancer	4.02e-05	0.00105	CcSEcCtD
Valrubicin—Asthenia—Melphalan—breast cancer	4.01e-05	0.00105	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—breast cancer	4.01e-05	0.0031	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ABL1—breast cancer	4.01e-05	0.0031	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—STAT5A—breast cancer	4.01e-05	0.0031	CbGpPWpGaD
Valrubicin—Gastrointestinal pain—Vinorelbine—breast cancer	4e-05	0.00105	CcSEcCtD
Valrubicin—Discomfort—Fluorouracil—breast cancer	3.98e-05	0.00104	CcSEcCtD
Valrubicin—Flatulence—Paclitaxel—breast cancer	3.97e-05	0.00104	CcSEcCtD
Valrubicin—Pruritus—Melphalan—breast cancer	3.96e-05	0.00104	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SIRT1—breast cancer	3.93e-05	0.00304	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CDK4—breast cancer	3.93e-05	0.00303	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—UBE2C—breast cancer	3.92e-05	0.00303	CbGpPWpGaD
Valrubicin—Asthenia—Goserelin—breast cancer	3.92e-05	0.00103	CcSEcCtD
Valrubicin—Diarrhoea—Tamoxifen—breast cancer	3.91e-05	0.00102	CcSEcCtD
Valrubicin—Irritability—Methotrexate—breast cancer	3.9e-05	0.00102	CcSEcCtD
Valrubicin—Back pain—Paclitaxel—breast cancer	3.9e-05	0.00102	CcSEcCtD
Valrubicin—Dizziness—Vinblastine—breast cancer	3.89e-05	0.00102	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCNE1—breast cancer	3.88e-05	0.003	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SMAD4—breast cancer	3.88e-05	0.003	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—breast cancer	3.88e-05	0.003	CbGpPWpGaD
Valrubicin—Body temperature increased—Vinorelbine—breast cancer	3.86e-05	0.00101	CcSEcCtD
Valrubicin—Abdominal pain—Vinorelbine—breast cancer	3.86e-05	0.00101	CcSEcCtD
Valrubicin—Oedema peripheral—Docetaxel—breast cancer	3.86e-05	0.00101	CcSEcCtD
Valrubicin—Pruritus—Goserelin—breast cancer	3.86e-05	0.00101	CcSEcCtD
Valrubicin—Feeling abnormal—Thiotepa—breast cancer	3.85e-05	0.00101	CcSEcCtD
Valrubicin—Diarrhoea—Melphalan—breast cancer	3.83e-05	0.001	CcSEcCtD
Valrubicin—Gastrointestinal pain—Thiotepa—breast cancer	3.82e-05	0.001	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—breast cancer	3.81e-05	0.00295	CbGpPWpGaD
Valrubicin—Nausea—Chlorambucil—breast cancer	3.81e-05	0.000999	CcSEcCtD
Valrubicin—Dizziness—Tamoxifen—breast cancer	3.78e-05	0.00099	CcSEcCtD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—breast cancer	3.78e-05	0.00292	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—SIRT1—breast cancer	3.78e-05	0.00292	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PLA2G4A—breast cancer	3.77e-05	0.00291	CbGpPWpGaD
Valrubicin—Oedema peripheral—Capecitabine—breast cancer	3.74e-05	0.00098	CcSEcCtD
Valrubicin—Vomiting—Vinblastine—breast cancer	3.74e-05	0.00098	CcSEcCtD
Valrubicin—Ill-defined disorder—Paclitaxel—breast cancer	3.74e-05	0.000979	CcSEcCtD
Valrubicin—Diarrhoea—Goserelin—breast cancer	3.73e-05	0.000978	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF1—breast cancer	3.73e-05	0.00288	CbGpPWpGaD
Valrubicin—Anaemia—Paclitaxel—breast cancer	3.72e-05	0.000975	CcSEcCtD
Valrubicin—Body temperature increased—Thiotepa—breast cancer	3.69e-05	0.000967	CcSEcCtD
Valrubicin—Abdominal pain—Thiotepa—breast cancer	3.69e-05	0.000967	CcSEcCtD
Valrubicin—Headache—Vinblastine—breast cancer	3.68e-05	0.000965	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—breast cancer	3.67e-05	0.00284	CbGpPWpGaD
Valrubicin—Musculoskeletal discomfort—Mitoxantrone—breast cancer	3.67e-05	0.000962	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—TYMS—breast cancer	3.66e-05	0.00283	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—CENPF—breast cancer	3.65e-05	0.00282	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—E2F1—breast cancer	3.65e-05	0.00282	CbGpPWpGaD
Valrubicin—Vomiting—Tamoxifen—breast cancer	3.63e-05	0.000952	CcSEcCtD
Valrubicin—Malaise—Paclitaxel—breast cancer	3.63e-05	0.000952	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—NCOR1—breast cancer	3.62e-05	0.0028	CbGpPWpGaD
Valrubicin—Dizziness—Goserelin—breast cancer	3.61e-05	0.000945	CcSEcCtD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—breast cancer	3.6e-05	0.00278	CbGpPWpGaD
Valrubicin—Rash—Tamoxifen—breast cancer	3.6e-05	0.000944	CcSEcCtD
Valrubicin—Dermatitis—Tamoxifen—breast cancer	3.6e-05	0.000943	CcSEcCtD
Valrubicin—Headache—Tamoxifen—breast cancer	3.58e-05	0.000938	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Gemcitabine—breast cancer	3.58e-05	0.000937	CcSEcCtD
Valrubicin—TOP2A—Methyltestosterone—Fluoxymesterone—breast cancer	3.58e-05	0.0278	CbGdCrCtD
Valrubicin—Vomiting—Melphalan—breast cancer	3.56e-05	0.000932	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—MRE11A—breast cancer	3.55e-05	0.00275	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—FOXM1—breast cancer	3.54e-05	0.00274	CbGpPWpGaD
Valrubicin—Rash—Melphalan—breast cancer	3.53e-05	0.000924	CcSEcCtD
Valrubicin—Dermatitis—Melphalan—breast cancer	3.52e-05	0.000923	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Fluorouracil—breast cancer	3.52e-05	0.000922	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—UBE2C—breast cancer	3.51e-05	0.00271	CbGpPWpGaD
Valrubicin—Asthenia—Vinorelbine—breast cancer	3.51e-05	0.000919	CcSEcCtD
Valrubicin—Nausea—Vinblastine—breast cancer	3.49e-05	0.000915	CcSEcCtD
Valrubicin—Doxorubicin—ABCG2—breast cancer	3.49e-05	0.0167	CrCbGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—breast cancer	3.49e-05	0.00269	CbGpPWpGaD
Valrubicin—Vomiting—Goserelin—breast cancer	3.47e-05	0.000909	CcSEcCtD
Valrubicin—Pruritus—Vinorelbine—breast cancer	3.46e-05	0.000906	CcSEcCtD
Valrubicin—Rash—Goserelin—breast cancer	3.44e-05	0.000901	CcSEcCtD
Valrubicin—Dermatitis—Goserelin—breast cancer	3.44e-05	0.000901	CcSEcCtD
Valrubicin—Chest pain—Paclitaxel—breast cancer	3.43e-05	0.000898	CcSEcCtD
Valrubicin—Myalgia—Paclitaxel—breast cancer	3.43e-05	0.000898	CcSEcCtD
Valrubicin—Headache—Goserelin—breast cancer	3.42e-05	0.000896	CcSEcCtD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—RB1—breast cancer	3.41e-05	0.00264	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—HIST1H2BC—breast cancer	3.41e-05	0.00263	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—HIST1H2BK—breast cancer	3.41e-05	0.00263	CbGpPWpGaD
Valrubicin—Nausea—Tamoxifen—breast cancer	3.39e-05	0.000889	CcSEcCtD
Valrubicin—Discomfort—Paclitaxel—breast cancer	3.39e-05	0.000888	CcSEcCtD
Valrubicin—Daunorubicin—CYP1A1—breast cancer	3.36e-05	0.0161	CrCbGaD
Valrubicin—Asthenia—Thiotepa—breast cancer	3.35e-05	0.000877	CcSEcCtD
Valrubicin—Diarrhoea—Vinorelbine—breast cancer	3.34e-05	0.000876	CcSEcCtD
Valrubicin—Nausea—Melphalan—breast cancer	3.32e-05	0.000871	CcSEcCtD
Valrubicin—Feeling abnormal—Irinotecan—breast cancer	3.32e-05	0.00087	CcSEcCtD
Valrubicin—Feeling abnormal—Mitoxantrone—breast cancer	3.32e-05	0.00087	CcSEcCtD
Valrubicin—Back pain—Docetaxel—breast cancer	3.3e-05	0.000865	CcSEcCtD
Valrubicin—Dysuria—Methotrexate—breast cancer	3.3e-05	0.000865	CcSEcCtD
Valrubicin—Pruritus—Thiotepa—breast cancer	3.3e-05	0.000865	CcSEcCtD
Valrubicin—Gastrointestinal pain—Irinotecan—breast cancer	3.3e-05	0.000864	CcSEcCtD
Valrubicin—Gastrointestinal pain—Mitoxantrone—breast cancer	3.3e-05	0.000864	CcSEcCtD
Valrubicin—Flatulence—Capecitabine—breast cancer	3.26e-05	0.000853	CcSEcCtD
Valrubicin—Nausea—Goserelin—breast cancer	3.24e-05	0.000849	CcSEcCtD
Valrubicin—Feeling abnormal—Gemcitabine—breast cancer	3.24e-05	0.000848	CcSEcCtD
Valrubicin—Dizziness—Vinorelbine—breast cancer	3.23e-05	0.000847	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FGFR1—breast cancer	3.23e-05	0.00249	CbGpPWpGaD
Valrubicin—Back pain—Capecitabine—breast cancer	3.2e-05	0.000838	CcSEcCtD
Valrubicin—Diarrhoea—Thiotepa—breast cancer	3.19e-05	0.000837	CcSEcCtD
Valrubicin—Body temperature increased—Irinotecan—breast cancer	3.19e-05	0.000835	CcSEcCtD
Valrubicin—Abdominal pain—Irinotecan—breast cancer	3.19e-05	0.000835	CcSEcCtD
Valrubicin—Body temperature increased—Mitoxantrone—breast cancer	3.19e-05	0.000835	CcSEcCtD
Valrubicin—Abdominal pain—Mitoxantrone—breast cancer	3.19e-05	0.000835	CcSEcCtD
Valrubicin—Feeling abnormal—Fluorouracil—breast cancer	3.18e-05	0.000834	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—FOXM1—breast cancer	3.17e-05	0.00245	CbGpPWpGaD
Valrubicin—Pneumonia—Methotrexate—breast cancer	3.17e-05	0.00083	CcSEcCtD
Valrubicin—Anaemia—Docetaxel—breast cancer	3.16e-05	0.000827	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—breast cancer	3.15e-05	0.00243	CbGpPWpGaD
Valrubicin—Vomiting—Vinorelbine—breast cancer	3.11e-05	0.000814	CcSEcCtD
Valrubicin—Body temperature increased—Gemcitabine—breast cancer	3.1e-05	0.000813	CcSEcCtD
Valrubicin—Dysuria—Epirubicin—breast cancer	3.09e-05	0.00081	CcSEcCtD
Valrubicin—Dizziness—Thiotepa—breast cancer	3.09e-05	0.000809	CcSEcCtD
Valrubicin—Rash—Vinorelbine—breast cancer	3.08e-05	0.000807	CcSEcCtD
Valrubicin—Dermatitis—Vinorelbine—breast cancer	3.08e-05	0.000807	CcSEcCtD
Valrubicin—Ill-defined disorder—Capecitabine—breast cancer	3.07e-05	0.000804	CcSEcCtD
Valrubicin—Headache—Vinorelbine—breast cancer	3.06e-05	0.000802	CcSEcCtD
Valrubicin—Anaemia—Capecitabine—breast cancer	3.06e-05	0.0008	CcSEcCtD
Valrubicin—Pollakiuria—Epirubicin—breast cancer	3.05e-05	0.0008	CcSEcCtD
Valrubicin—Body temperature increased—Fluorouracil—breast cancer	3.05e-05	0.0008	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—HIST1H2BK—breast cancer	3.05e-05	0.00236	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—HIST1H2BC—breast cancer	3.05e-05	0.00236	CbGpPWpGaD
Valrubicin—Haematuria—Methotrexate—breast cancer	3e-05	0.000787	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Paclitaxel—breast cancer	3e-05	0.000785	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ATM—breast cancer	2.99e-05	0.00231	CbGpPWpGaD
Valrubicin—Hyperglycaemia—Epirubicin—breast cancer	2.98e-05	0.000781	CcSEcCtD
Valrubicin—Malaise—Capecitabine—breast cancer	2.98e-05	0.000781	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—LEP—breast cancer	2.98e-05	0.0023	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—breast cancer	2.97e-05	0.0023	CbGpPWpGaD
Valrubicin—Vomiting—Thiotepa—breast cancer	2.97e-05	0.000778	CcSEcCtD
Valrubicin—Pneumonia—Epirubicin—breast cancer	2.96e-05	0.000777	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—breast cancer	2.96e-05	0.00229	CbGpPWpGaD
Valrubicin—Rash—Thiotepa—breast cancer	2.94e-05	0.000771	CcSEcCtD
Valrubicin—Dermatitis—Thiotepa—breast cancer	2.94e-05	0.00077	CcSEcCtD
Valrubicin—Headache—Thiotepa—breast cancer	2.92e-05	0.000766	CcSEcCtD
Valrubicin—Chest pain—Docetaxel—breast cancer	2.91e-05	0.000762	CcSEcCtD
Valrubicin—Myalgia—Docetaxel—breast cancer	2.91e-05	0.000762	CcSEcCtD
Valrubicin—Nausea—Vinorelbine—breast cancer	2.9e-05	0.000761	CcSEcCtD
Valrubicin—Asthenia—Mitoxantrone—breast cancer	2.89e-05	0.000758	CcSEcCtD
Valrubicin—Asthenia—Irinotecan—breast cancer	2.89e-05	0.000758	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKBIA—breast cancer	2.89e-05	0.00223	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—breast cancer	2.89e-05	0.00223	CbGpPWpGaD
Valrubicin—Urinary tract infection—Epirubicin—breast cancer	2.86e-05	0.00075	CcSEcCtD
Valrubicin—Dysuria—Doxorubicin—breast cancer	2.86e-05	0.000749	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—CDK4—breast cancer	2.86e-05	0.00221	CbGpPWpGaD
Valrubicin—Pollakiuria—Doxorubicin—breast cancer	2.83e-05	0.00074	CcSEcCtD
Valrubicin—Asthenia—Gemcitabine—breast cancer	2.82e-05	0.000738	CcSEcCtD
Valrubicin—Myalgia—Capecitabine—breast cancer	2.81e-05	0.000737	CcSEcCtD
Valrubicin—Chest pain—Capecitabine—breast cancer	2.81e-05	0.000737	CcSEcCtD
Valrubicin—Haematuria—Epirubicin—breast cancer	2.81e-05	0.000736	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—breast cancer	2.8e-05	0.00216	CbGpPWpGaD
Valrubicin—TOP2A—Cytarabine—Gemcitabine—breast cancer	2.79e-05	0.0217	CbGdCrCtD
Valrubicin—Discomfort—Capecitabine—breast cancer	2.78e-05	0.000728	CcSEcCtD
Valrubicin—Pruritus—Gemcitabine—breast cancer	2.78e-05	0.000728	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—NOS2—breast cancer	2.78e-05	0.00214	CbGpPWpGaD
Valrubicin—Nausea—Thiotepa—breast cancer	2.77e-05	0.000726	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—breast cancer	2.77e-05	0.00214	CbGpPWpGaD
Valrubicin—Hyperglycaemia—Doxorubicin—breast cancer	2.76e-05	0.000723	CcSEcCtD
Valrubicin—Diarrhoea—Irinotecan—breast cancer	2.76e-05	0.000723	CcSEcCtD
Valrubicin—Diarrhoea—Mitoxantrone—breast cancer	2.76e-05	0.000723	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—RAD51—breast cancer	2.75e-05	0.00212	CbGpPWpGaD
Valrubicin—Pneumonia—Doxorubicin—breast cancer	2.74e-05	0.000719	CcSEcCtD
Valrubicin—Pruritus—Fluorouracil—breast cancer	2.73e-05	0.000716	CcSEcCtD
Valrubicin—Feeling abnormal—Paclitaxel—breast cancer	2.71e-05	0.00071	CcSEcCtD
Valrubicin—Gastrointestinal pain—Paclitaxel—breast cancer	2.69e-05	0.000704	CcSEcCtD
Valrubicin—Diarrhoea—Gemcitabine—breast cancer	2.69e-05	0.000704	CcSEcCtD
Valrubicin—Dizziness—Irinotecan—breast cancer	2.67e-05	0.000698	CcSEcCtD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—breast cancer	2.66e-05	0.00205	CbGpPWpGaD
Valrubicin—Urinary tract infection—Doxorubicin—breast cancer	2.65e-05	0.000694	CcSEcCtD
Valrubicin—Diarrhoea—Fluorouracil—breast cancer	2.64e-05	0.000692	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—breast cancer	2.61e-05	0.00201	CbGpPWpGaD
Valrubicin—Oedema peripheral—Epirubicin—breast cancer	2.61e-05	0.000683	CcSEcCtD
Valrubicin—Haematuria—Doxorubicin—breast cancer	2.6e-05	0.000681	CcSEcCtD
Valrubicin—Body temperature increased—Paclitaxel—breast cancer	2.6e-05	0.000681	CcSEcCtD
Valrubicin—Abdominal pain—Paclitaxel—breast cancer	2.6e-05	0.000681	CcSEcCtD
Valrubicin—TOP2A—Daunorubicin—Epirubicin—breast cancer	2.59e-05	0.0201	CbGdCrCtD
Valrubicin—TOP2A—Idarubicin—Epirubicin—breast cancer	2.59e-05	0.0201	CbGdCrCtD
Valrubicin—TOP2A—Doxorubicin—Epirubicin—breast cancer	2.59e-05	0.0201	CbGdCrCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—breast cancer	2.56e-05	0.00198	CbGpPWpGaD
Valrubicin—Vomiting—Irinotecan—breast cancer	2.56e-05	0.000671	CcSEcCtD
Valrubicin—Vomiting—Mitoxantrone—breast cancer	2.56e-05	0.000671	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—AURKA—breast cancer	2.56e-05	0.00198	CbGpPWpGaD
Valrubicin—Dizziness—Fluorouracil—breast cancer	2.55e-05	0.000669	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—NBN—breast cancer	2.55e-05	0.00197	CbGpPWpGaD
Valrubicin—Rash—Irinotecan—breast cancer	2.54e-05	0.000666	CcSEcCtD
Valrubicin—Rash—Mitoxantrone—breast cancer	2.54e-05	0.000666	CcSEcCtD
Valrubicin—Dermatitis—Mitoxantrone—breast cancer	2.54e-05	0.000665	CcSEcCtD
Valrubicin—Dermatitis—Irinotecan—breast cancer	2.54e-05	0.000665	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Docetaxel—breast cancer	2.54e-05	0.000665	CcSEcCtD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CCND1—breast cancer	2.54e-05	0.00196	CbGpPWpGaD
Valrubicin—Headache—Mitoxantrone—breast cancer	2.53e-05	0.000662	CcSEcCtD
Valrubicin—Headache—Irinotecan—breast cancer	2.53e-05	0.000662	CcSEcCtD
Valrubicin—Vomiting—Gemcitabine—breast cancer	2.5e-05	0.000654	CcSEcCtD
Valrubicin—Rash—Gemcitabine—breast cancer	2.48e-05	0.000649	CcSEcCtD
Valrubicin—Dermatitis—Gemcitabine—breast cancer	2.47e-05	0.000648	CcSEcCtD
Valrubicin—Headache—Gemcitabine—breast cancer	2.46e-05	0.000644	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Capecitabine—breast cancer	2.46e-05	0.000644	CcSEcCtD
Valrubicin—Vomiting—Fluorouracil—breast cancer	2.45e-05	0.000643	CcSEcCtD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—breast cancer	2.45e-05	0.00189	CbGpPWpGaD
Valrubicin—Rash—Fluorouracil—breast cancer	2.43e-05	0.000638	CcSEcCtD
Valrubicin—Dermatitis—Fluorouracil—breast cancer	2.43e-05	0.000637	CcSEcCtD
Valrubicin—Headache—Fluorouracil—breast cancer	2.42e-05	0.000634	CcSEcCtD
Valrubicin—Oedema peripheral—Doxorubicin—breast cancer	2.41e-05	0.000632	CcSEcCtD
Valrubicin—TOP2A—Epirubicin—Doxorubicin—breast cancer	2.4e-05	0.0186	CbGdCrCtD
Valrubicin—TOP2A—Daunorubicin—Doxorubicin—breast cancer	2.4e-05	0.0186	CbGdCrCtD
Valrubicin—TOP2A—Idarubicin—Doxorubicin—breast cancer	2.4e-05	0.0186	CbGdCrCtD
Valrubicin—Nausea—Irinotecan—breast cancer	2.39e-05	0.000627	CcSEcCtD
Valrubicin—Nausea—Mitoxantrone—breast cancer	2.39e-05	0.000627	CcSEcCtD
Valrubicin—Back pain—Methotrexate—breast cancer	2.38e-05	0.000624	CcSEcCtD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—breast cancer	2.37e-05	0.00183	CbGpPWpGaD
Valrubicin—Asthenia—Paclitaxel—breast cancer	2.36e-05	0.000618	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—SERPINE1—breast cancer	2.34e-05	0.00181	CbGpPWpGaD
Valrubicin—Nausea—Gemcitabine—breast cancer	2.33e-05	0.000611	CcSEcCtD
Valrubicin—TOP2A—Norethindrone—Fluoxymesterone—breast cancer	2.33e-05	0.0181	CbGdCrCtD
Valrubicin—Pruritus—Paclitaxel—breast cancer	2.33e-05	0.000609	CcSEcCtD
Valrubicin—Feeling abnormal—Docetaxel—breast cancer	2.3e-05	0.000602	CcSEcCtD
Valrubicin—Nausea—Fluorouracil—breast cancer	2.29e-05	0.000601	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—AURKA—breast cancer	2.29e-05	0.00177	CbGpPWpGaD
Valrubicin—Ill-defined disorder—Methotrexate—breast cancer	2.28e-05	0.000598	CcSEcCtD
Valrubicin—Gastrointestinal pain—Docetaxel—breast cancer	2.28e-05	0.000597	CcSEcCtD
Valrubicin—Anaemia—Methotrexate—breast cancer	2.27e-05	0.000596	CcSEcCtD
Valrubicin—Flatulence—Epirubicin—breast cancer	2.27e-05	0.000595	CcSEcCtD
Valrubicin—Diarrhoea—Paclitaxel—breast cancer	2.25e-05	0.000589	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—HSP90AA1—breast cancer	2.24e-05	0.00173	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—breast cancer	2.24e-05	0.00173	CbGpPWpGaD
Valrubicin—Back pain—Epirubicin—breast cancer	2.23e-05	0.000584	CcSEcCtD
Valrubicin—Feeling abnormal—Capecitabine—breast cancer	2.22e-05	0.000582	CcSEcCtD
Valrubicin—Malaise—Methotrexate—breast cancer	2.22e-05	0.000581	CcSEcCtD
Valrubicin—Gastrointestinal pain—Capecitabine—breast cancer	2.21e-05	0.000578	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—breast cancer	2.21e-05	0.0017	CbGpPWpGaD
Valrubicin—Abdominal pain—Docetaxel—breast cancer	2.2e-05	0.000577	CcSEcCtD
Valrubicin—Body temperature increased—Docetaxel—breast cancer	2.2e-05	0.000577	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	2.2e-05	0.0017	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	2.17e-05	0.00168	CbGpPWpGaD
Valrubicin—Dizziness—Paclitaxel—breast cancer	2.17e-05	0.00057	CcSEcCtD
Valrubicin—Daunorubicin—CYP3A4—breast cancer	2.15e-05	0.0103	CrCbGaD
Valrubicin—Ill-defined disorder—Epirubicin—breast cancer	2.14e-05	0.00056	CcSEcCtD
Valrubicin—Body temperature increased—Capecitabine—breast cancer	2.13e-05	0.000559	CcSEcCtD
Valrubicin—Abdominal pain—Capecitabine—breast cancer	2.13e-05	0.000559	CcSEcCtD
Valrubicin—Anaemia—Epirubicin—breast cancer	2.13e-05	0.000558	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—breast cancer	2.13e-05	0.00164	CbGpPWpGaD
Valrubicin—Flatulence—Doxorubicin—breast cancer	2.1e-05	0.00055	CcSEcCtD
Valrubicin—Chest pain—Methotrexate—breast cancer	2.1e-05	0.000549	CcSEcCtD
Valrubicin—Myalgia—Methotrexate—breast cancer	2.1e-05	0.000549	CcSEcCtD
Valrubicin—Vomiting—Paclitaxel—breast cancer	2.09e-05	0.000548	CcSEcCtD
Valrubicin—Malaise—Epirubicin—breast cancer	2.08e-05	0.000544	CcSEcCtD
Valrubicin—Rash—Paclitaxel—breast cancer	2.07e-05	0.000543	CcSEcCtD
Valrubicin—Dermatitis—Paclitaxel—breast cancer	2.07e-05	0.000543	CcSEcCtD
Valrubicin—Discomfort—Methotrexate—breast cancer	2.07e-05	0.000542	CcSEcCtD
Valrubicin—Back pain—Doxorubicin—breast cancer	2.06e-05	0.00054	CcSEcCtD
Valrubicin—Headache—Paclitaxel—breast cancer	2.06e-05	0.00054	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—CHEK2—breast cancer	2.05e-05	0.00158	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—MYC—breast cancer	2.03e-05	0.00157	CbGpPWpGaD
Valrubicin—Doxorubicin—CYP2D6—breast cancer	2.03e-05	0.00973	CrCbGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	2.01e-05	0.00156	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—HSP90AA1—breast cancer	2e-05	0.00155	CbGpPWpGaD
Valrubicin—TOP2A—Azacitidine—Gemcitabine—breast cancer	2e-05	0.0156	CbGdCrCtD
Valrubicin—Asthenia—Docetaxel—breast cancer	2e-05	0.000524	CcSEcCtD
Valrubicin—Ill-defined disorder—Doxorubicin—breast cancer	1.98e-05	0.000518	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	1.97e-05	0.00152	CbGpPWpGaD
Valrubicin—Pruritus—Docetaxel—breast cancer	1.97e-05	0.000517	CcSEcCtD
Valrubicin—Anaemia—Doxorubicin—breast cancer	1.97e-05	0.000516	CcSEcCtD
Valrubicin—Chest pain—Epirubicin—breast cancer	1.96e-05	0.000514	CcSEcCtD
Valrubicin—Myalgia—Epirubicin—breast cancer	1.96e-05	0.000514	CcSEcCtD
Valrubicin—Nausea—Paclitaxel—breast cancer	1.95e-05	0.000512	CcSEcCtD
Valrubicin—Discomfort—Epirubicin—breast cancer	1.94e-05	0.000508	CcSEcCtD
Valrubicin—Asthenia—Capecitabine—breast cancer	1.94e-05	0.000507	CcSEcCtD
Valrubicin—Malaise—Doxorubicin—breast cancer	1.92e-05	0.000503	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	1.92e-05	0.00148	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—BRCA1—breast cancer	1.92e-05	0.00148	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	1.92e-05	0.00148	CbGpPWpGaD
Valrubicin—Pruritus—Capecitabine—breast cancer	1.91e-05	0.0005	CcSEcCtD
Valrubicin—Diarrhoea—Docetaxel—breast cancer	1.91e-05	0.0005	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	1.9e-05	0.00147	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CCNE1—breast cancer	1.88e-05	0.00145	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	1.86e-05	0.00144	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	1.85e-05	0.00143	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—TYMS—breast cancer	1.85e-05	0.00143	CbGpPWpGaD
Valrubicin—Diarrhoea—Capecitabine—breast cancer	1.85e-05	0.000484	CcSEcCtD
Valrubicin—Dizziness—Docetaxel—breast cancer	1.84e-05	0.000483	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—JUN—breast cancer	1.84e-05	0.00142	CbGpPWpGaD
Valrubicin—Musculoskeletal discomfort—Methotrexate—breast cancer	1.83e-05	0.000479	CcSEcCtD
Valrubicin—Myalgia—Doxorubicin—breast cancer	1.81e-05	0.000475	CcSEcCtD
Valrubicin—Chest pain—Doxorubicin—breast cancer	1.81e-05	0.000475	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	1.81e-05	0.0014	CbGpPWpGaD
Valrubicin—Discomfort—Doxorubicin—breast cancer	1.79e-05	0.00047	CcSEcCtD
Valrubicin—Daunorubicin—ABCB1—breast cancer	1.79e-05	0.00856	CrCbGaD
Valrubicin—Dizziness—Capecitabine—breast cancer	1.78e-05	0.000467	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—PTEN—breast cancer	1.78e-05	0.00137	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—H2AFX—breast cancer	1.78e-05	0.00137	CbGpPWpGaD
Valrubicin—Vomiting—Docetaxel—breast cancer	1.77e-05	0.000464	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—E2F1—breast cancer	1.77e-05	0.00136	CbGpPWpGaD
Valrubicin—Rash—Docetaxel—breast cancer	1.76e-05	0.00046	CcSEcCtD
Valrubicin—Dermatitis—Docetaxel—breast cancer	1.76e-05	0.00046	CcSEcCtD
Valrubicin—Headache—Docetaxel—breast cancer	1.75e-05	0.000457	CcSEcCtD
Valrubicin—Doxorubicin—CYP3A4—breast cancer	1.74e-05	0.00835	CrCbGaD
Valrubicin—TOP2A—Circadian rythm related genes—MAPK8—breast cancer	1.74e-05	0.00134	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—BRCA2—breast cancer	1.74e-05	0.00134	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	1.72e-05	0.00133	CbGpPWpGaD
Valrubicin—Vomiting—Capecitabine—breast cancer	1.72e-05	0.000449	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Epirubicin—breast cancer	1.71e-05	0.000449	CcSEcCtD
Valrubicin—Rash—Capecitabine—breast cancer	1.7e-05	0.000446	CcSEcCtD
Valrubicin—Dermatitis—Capecitabine—breast cancer	1.7e-05	0.000445	CcSEcCtD
Valrubicin—Headache—Capecitabine—breast cancer	1.69e-05	0.000443	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—CCNE1—breast cancer	1.68e-05	0.0013	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	1.67e-05	0.00129	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—BIRC5—breast cancer	1.66e-05	0.00128	CbGpPWpGaD
Valrubicin—Nausea—Docetaxel—breast cancer	1.66e-05	0.000434	CcSEcCtD
Valrubicin—Feeling abnormal—Methotrexate—breast cancer	1.66e-05	0.000434	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—TYMS—breast cancer	1.65e-05	0.00128	CbGpPWpGaD
Valrubicin—Gastrointestinal pain—Methotrexate—breast cancer	1.64e-05	0.00043	CcSEcCtD
Valrubicin—Nausea—Capecitabine—breast cancer	1.6e-05	0.00042	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—H2AFX—breast cancer	1.59e-05	0.00123	CbGpPWpGaD
Valrubicin—Body temperature increased—Methotrexate—breast cancer	1.59e-05	0.000416	CcSEcCtD
Valrubicin—Abdominal pain—Methotrexate—breast cancer	1.59e-05	0.000416	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.58e-05	0.000415	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	1.58e-05	0.00122	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—E2F1—breast cancer	1.58e-05	0.00122	CbGpPWpGaD
Valrubicin—Feeling abnormal—Epirubicin—breast cancer	1.55e-05	0.000406	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	1.54e-05	0.00119	CbGpPWpGaD
Valrubicin—Gastrointestinal pain—Epirubicin—breast cancer	1.54e-05	0.000403	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	1.54e-05	0.00119	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CDK2—breast cancer	1.52e-05	0.00118	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	1.51e-05	0.00116	CbGpPWpGaD
Valrubicin—Body temperature increased—Epirubicin—breast cancer	1.49e-05	0.000389	CcSEcCtD
Valrubicin—Abdominal pain—Epirubicin—breast cancer	1.49e-05	0.000389	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—BIRC5—breast cancer	1.48e-05	0.00115	CbGpPWpGaD
Valrubicin—Doxorubicin—ABCB1—breast cancer	1.45e-05	0.00695	CrCbGaD
Valrubicin—Asthenia—Methotrexate—breast cancer	1.44e-05	0.000378	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CDK4—breast cancer	1.44e-05	0.00111	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—TERT—breast cancer	1.44e-05	0.00111	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	1.44e-05	0.00111	CbGpPWpGaD
Valrubicin—Feeling abnormal—Doxorubicin—breast cancer	1.43e-05	0.000375	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	1.42e-05	0.0011	CbGpPWpGaD
Valrubicin—Gastrointestinal pain—Doxorubicin—breast cancer	1.42e-05	0.000373	CcSEcCtD
Valrubicin—Pruritus—Methotrexate—breast cancer	1.42e-05	0.000372	CcSEcCtD
Valrubicin—Abdominal pain—Doxorubicin—breast cancer	1.37e-05	0.00036	CcSEcCtD
Valrubicin—Body temperature increased—Doxorubicin—breast cancer	1.37e-05	0.00036	CcSEcCtD
Valrubicin—Diarrhoea—Methotrexate—breast cancer	1.37e-05	0.00036	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—CDK2—breast cancer	1.36e-05	0.00105	CbGpPWpGaD
Valrubicin—Asthenia—Epirubicin—breast cancer	1.35e-05	0.000353	CcSEcCtD
Valrubicin—Pruritus—Epirubicin—breast cancer	1.33e-05	0.000348	CcSEcCtD
Valrubicin—Dizziness—Methotrexate—breast cancer	1.33e-05	0.000348	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	1.31e-05	0.00101	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—ATM—breast cancer	1.29e-05	0.000999	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—CDK4—breast cancer	1.29e-05	0.000995	CbGpPWpGaD
Valrubicin—Diarrhoea—Epirubicin—breast cancer	1.29e-05	0.000337	CcSEcCtD
Valrubicin—Vomiting—Methotrexate—breast cancer	1.28e-05	0.000335	CcSEcCtD
Valrubicin—Rash—Methotrexate—breast cancer	1.27e-05	0.000332	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	1.27e-05	0.000977	CbGpPWpGaD
Valrubicin—Dermatitis—Methotrexate—breast cancer	1.27e-05	0.000331	CcSEcCtD
Valrubicin—Headache—Methotrexate—breast cancer	1.26e-05	0.00033	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—RB1—breast cancer	1.25e-05	0.000967	CbGpPWpGaD
Valrubicin—Asthenia—Doxorubicin—breast cancer	1.25e-05	0.000327	CcSEcCtD
Valrubicin—Dizziness—Epirubicin—breast cancer	1.24e-05	0.000326	CcSEcCtD
Valrubicin—Pruritus—Doxorubicin—breast cancer	1.23e-05	0.000322	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—TP53—breast cancer	1.21e-05	0.000938	CbGpPWpGaD
Valrubicin—Vomiting—Epirubicin—breast cancer	1.2e-05	0.000313	CcSEcCtD
Valrubicin—Nausea—Methotrexate—breast cancer	1.19e-05	0.000313	CcSEcCtD
Valrubicin—Diarrhoea—Doxorubicin—breast cancer	1.19e-05	0.000312	CcSEcCtD
Valrubicin—Rash—Epirubicin—breast cancer	1.19e-05	0.00031	CcSEcCtD
Valrubicin—Dermatitis—Epirubicin—breast cancer	1.18e-05	0.00031	CcSEcCtD
Valrubicin—Headache—Epirubicin—breast cancer	1.18e-05	0.000308	CcSEcCtD
Valrubicin—Dizziness—Doxorubicin—breast cancer	1.15e-05	0.000301	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—RB1—breast cancer	1.12e-05	0.000865	CbGpPWpGaD
Valrubicin—Nausea—Epirubicin—breast cancer	1.12e-05	0.000292	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—IL6—breast cancer	1.11e-05	0.000859	CbGpPWpGaD
Valrubicin—Vomiting—Doxorubicin—breast cancer	1.11e-05	0.00029	CcSEcCtD
Valrubicin—Rash—Doxorubicin—breast cancer	1.1e-05	0.000287	CcSEcCtD
Valrubicin—Dermatitis—Doxorubicin—breast cancer	1.1e-05	0.000287	CcSEcCtD
Valrubicin—Headache—Doxorubicin—breast cancer	1.09e-05	0.000285	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.07e-05	0.000825	CbGpPWpGaD
Valrubicin—Nausea—Doxorubicin—breast cancer	1.03e-05	0.000271	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CDKN1B—breast cancer	9.75e-06	0.000753	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—MDM2—breast cancer	9.55e-06	0.000737	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CCND1—breast cancer	9.3e-06	0.000718	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CDKN1A—breast cancer	9e-06	0.000695	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—CDKN1B—breast cancer	8.72e-06	0.000673	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—CCND1—breast cancer	8.31e-06	0.000642	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—CDKN1A—breast cancer	8.04e-06	0.000621	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—MAPK3—breast cancer	7.67e-06	0.000592	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—MYC—breast cancer	7.46e-06	0.000576	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—MAPK3—breast cancer	6.86e-06	0.00053	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—MYC—breast cancer	6.67e-06	0.000515	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—TP53—breast cancer	5.48e-06	0.000423	CbGpPWpGaD
